ClinicalTrials.gg

Program

MH004

A development code. Also written as “MH004 1.0% Ointment”, “MH004 Ointment” and “MH004 0.1% Ointment”.

Its studies are mostly in Dermatitis, Atopic · Vitiligo, led by Minghui Pharmaceutical.

Furthest: phase 3, since Sep 12, 20255 company-led studies, 1 open or runningNext primary completion: Feb 23, 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Minghui Pharmaceutical51 open or runningphase 3since Sep 12, 2025Mar 19, 2021Feb 23, 2028phase 3 · NCT07682506

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 19, 2021First study: phase 1 study in Dermatitis, AtopicFirst studyNCT04815148 · 72 enrolled
  2. Sep 12, 2025Phase 3 study in Dermatitis, AtopicNCT07185282 · 375 enrolled · China
  3. Sep 12, 20252 phase 2 studiesNCT07182864, NCT07181187
  4. Jun 28, 2026Phase 3 study in VitiligoNCT07682506 · 405 planned · China

Ahead

  1. Feb 23, 2028Primary completion: phase 3 study in VitiligoNCT07682506

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07682506Vitiligo · China3RecruitingFeb 23, 2028405
NCT07185282Dermatitis, Atopic · China3CompletedDec 13, 2024375
NCT07182864Dermatitis, Atopic · China2CompletedSep 8, 2022160
NCT07181187Vitiligo · China2CompletedSep 24, 2025156
NCT04815148Dermatitis, Atopic1UNKNOWNMar 31, 202272

How it is read

Names in the registry

  • “MH004 1.0% Ointment”, 2 entries
  • “MH004 Ointment”, 2 entries
  • “MH004 0.1% Ointment”, 1 entry
  • “MH004 0.3% Ointment”, 1 entry
  • “MH004 3.0% Ointment”, 1 entry

Codes read as this program: MH004.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.